Search

Your search keyword '"Malacarne F"' showing total 167 results
Start Over Author "Malacarne F"
167 results on '"Malacarne F"'

18. Soddisfazione dei pazienti e degli operatori in relazione all’assistenza clinica fornita dai medici specializzandi e dagli studenti di medicina: L’esperienza dell’ospedale accademico Santa Maria della Misericordia (SMM) di Udine

Author

D’Angelo, M, Perri, G, Malacarne, F, Pellizzaro, A, Poletto, M, Menegazzi, G, Brunelli, L, Bevilacqua, G, Castriotta, L, Londero, C, and Brusaferro, S.

Subjects
Questionari soddisfazione, Didattica, Qualità assistenziale, Questionari soddisfazione, Formazione, Didattica, Qualità assistenziale, Formazione
Published
2017

22. Effect of combined lamivudine and interferon alpha treatment on the T-cell response to HBV core peptides in paediatric patients infected with chronic hepatitis B virus

Author

Cavers, M, Aw, M, D'Antiga, L, Malacarne, F, Williams, R, Moorat, A, Greensmith, M, Atkins, M, Mieli-Vergani, G, Vergani, D, Cavers M, Aw M, D'Antiga L, Malacarne F, Williams R, Moorat A, Greensmith M, Atkins M, Mieli-Vergani G, Vergani D, Cavers, M, Aw, M, D'Antiga, L, Malacarne, F, Williams, R, Moorat, A, Greensmith, M, Atkins, M, Mieli-Vergani, G, Vergani, D, Cavers M, Aw M, D'Antiga L, Malacarne F, Williams R, Moorat A, Greensmith M, Atkins M, Mieli-Vergani G, and Vergani D

Published
2001

25. Intervento

Author

Malacarne, F.

Subjects
lcsh:Industries. Land use. Labor, lcsh:HD28-9999
Abstract

Aestimum, Seminari 7 (1986)

Published
2009

27. Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Author

Tincani A, Morozzi G, Antonella Maria Vittoria Afeltra, Alessandri C, Allegri F, Bistoni O, Bizzaro N, Caccavo D, Galeazzi M, Gerli R, Giovannelli L, Longobardo G, Lotzniker M, Malacarne F, Migliorini P, Parodi A, Pregnolato F, Radice A, Riccieri V, Ruffelli M, Ra, Sinico, Tozzoli R, Villalta D, Marcolongo R, Meroni P, and Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Published
2007

28. Antiprothrombin antibodies: a comparative analysis of home made and commercial methods. A collaborative study of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)'

Author

Tincani, A, Morozzi, G, Afeltra, A, Alessandri, Cristiano, Allegri, F, Bistoni, O, Bizzaro, N, Caccavo, D, Galeazzi, M, Gerli, R, Giovannelli, L, Longobardo, G, Lotzniker, M, Malacarne, F, Migliorini, P, Parodi, A, Pregnolato, F, Radice, A, Riccieri, Valeria, Ruffelli, M, Sinico, Ra, Tozzoli, R, Villalta, D, Marcolongo, R, and Meroni, P.

Published
2007

29. Displacement of the inferior vena cava as a factor limiting catheter performance in long-term hemodialysis patients

Author

Fabio Fabbian, Malacarne, F., Russo, G., Galeotti, R., Gresta, E., Cantelli, S., and Catizone, L.

Subjects
kidney polycystic disease, Nephrology, arteriovenous shunt, cava vein disease, Surgery
Abstract

We report a case of a lady affected by autosomal dominat polycystic kidney disease who had been on hemodialyis for 24 years. She has exhausted all options for arterious-venous fistula. The presence of an acquired anatomical abnormality was an obstacle in order to get appropriate blood flow from standard tunnelled femoral catheters. The enlarged right kidney was pushing the inferior vena cava to the left side of the abdomen, and the abnormality was demonstrated by phlebography. Only after placing a cuffed catheter 53 cm long in her left femoral vein we could dialyze efficiently. Venography is mandatory before placing a cuffed catheter especially in uremic patients with long history of access failure, because it saves costs.

Published
2007

30. Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Author

Tincani, Angela, Morozzi, G, Afeltra, A, Alessandri, C, Allegri, F, Bistoni, O, Bizzaro, N, Caccavo, D, Galeazzi, M, Gerli, R, Giovannelli, L, Longobardo, G, Lotzniker, M, Malacarne, F, Migliorini, P, Parodi, A, Pregnolato, F, Radice, A, Riccieri, V, Ruffelli, M, Sinico, Ra, Tozzoli, R, Villalta, D, Marcolongo, R, Meroni, P, Forum, and INTERDISCIPLINARE PER LA RICERCA NELLE MALATTIE AUTOIMMUNI FIRMA

Published
2007

42. Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Author

Tincani, A, Morozzi, G, Afeltra, A, Alessandri, C, Allegri, F, Bistoni, O, Bizzaro, N, Caccavo, D, Galeazzi, M, Gerli, R, Giovannelli, L, Longobardo, G, Lotzniker, M, Malacarne, F, Migliorini, P, Parodi, A, Pregnolato, F, Radice, A, Riccieri, V, Ruffelli, M, Sinico, R, Tozzoli, R, Villalta, D, Marcolongo, R, Meroni, P, Meroni, P., SINICO, RENATO ALBERTO, Tincani, A, Morozzi, G, Afeltra, A, Alessandri, C, Allegri, F, Bistoni, O, Bizzaro, N, Caccavo, D, Galeazzi, M, Gerli, R, Giovannelli, L, Longobardo, G, Lotzniker, M, Malacarne, F, Migliorini, P, Parodi, A, Pregnolato, F, Radice, A, Riccieri, V, Ruffelli, M, Sinico, R, Tozzoli, R, Villalta, D, Marcolongo, R, Meroni, P, Meroni, P., and SINICO, RENATO ALBERTO

Abstract

Objective: Prothrombin (PT) is a target for antibodies with lupus anticoagulant (LA) activity, suggesting the possible application of anti-prothrombin antibody (aPT) assays in patients with antiphospholipid syndrome (APS). Different methods - both homemade and commercial - for the detection of aPT are available, but they seem to produce conflicting results. The purpose of this study was to compare the performance of different assays on a set of well-characterized serum samples. Patients and methods: Sera were gathered from 4 FIRMA institutions, and distributed to 15 participating centres. Forty-five samples were from patients positive for LA and/or anticardiolipin antibodies (aCL) with or without APS, and 15 were from rheumatoid arthritis (RA) patients negative for antiphospholipid antibodies. The samples were evaluated for IgG and IgM antibodies using a homemade direct aPT assay (method 1), a homemade phosphatidylserine-dependent aPT assay (aPS/PT, method 2), and two different commercial kits (methods 3 and 4). In addition, a commercial kit for the detection of IgG-A-M aPT (method 5) was used. Results: Inter-laboratory results for the 5 methods were not always comparable when different methods were used. Good inter-assay concordance was found for IgG antibodies evaluated using methods 1, 3, and 4 (Cohen k > 0.4), while the IgM results were discordant between assays. In patients with thrombosis and pregnancy losses, method 5 performed better than the others. Conclusion: While aPT and aPS/PT assays could be of interest from a clinical perspective, their routine performance cannot yet be recommended because of problems connected with the reproducibility and interpretation of the results

Published
2007

45. Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)

Author

Franceschini, F, Cavazzana, I, Malacarne, F, Airo, P, Cattaneo, R, Del Papa, N, Radice, A, SINICO, RENATO ALBERTO, Franceschini, F, Cavazzana, I, Malacarne, F, Airo, P, Cattaneo, R, Del Papa, N, Radice, A, and Sinico, R

Subjects
cardiovascular risk, Clinical Trials as Topic, Cyclooxygenase 2 Inhibitors, cyclooxygenase-2 inhibitors, prothrombotic effects, Membrane Proteins, Rheumatoid arthritis, anti-SSA, Thrombosis, prostaglandins, Isoenzymes, Mice, Dogs, Cardiovascular Diseases, Cyclooxygenase 2, Prostaglandin-Endoperoxide Synthases, Risk Factors, Meeting Abstract, Commentary, Oral Presentation, Animals, Humans, Cyclooxygenase Inhibitors, Rabbits
Abstract

Selective cyclooxygenase-2 (COX-2) inhibitors were developed to reduce the gastrointestinal toxicity of conventional nonsteroidal anti-inflammatory agents. However, COX-2 inhibitors decrease prostacyclin production and may disrupt the normal homeostatic balance, leading to a prothrombotic state and offsetting the potential gastrointestinal benefits. Available clinical data and basic biological studies raise significant concern about the potential prothrombotic effect of this class of drugs. Two recent studies with a newer, more selective COX-2 inhibitor have added to the already existing concern about the cardiovascular safety of these agents. The widespread use of these agents mandates prospective, randomized evaluation of the cardiovascular safety of COX-2 inhibitors.

Published
2003

50. Eritropoietina e Sport

Author

De Paoli Vitali, E., Ricci, Giorgio, Masotti, M., Casoni, I., Vedovato, M., Malacarne, F., Gilli, P., and Conconi, F.

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results